Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

A new engineered treatment shows promise in curing heart fibrosis.

A new Wnt surrogate specifically targets the Frizzled7 receptor, promoting organoid formation and hair growth.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

New compounds show promise as nonsteroidal treatments for hair loss.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Certain drugs that block specific enzymes can help treat prostate diseases.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

CRH promotes fat production in skin cells, affecting conditions like acne.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Androgen receptors help prostate cancer cells grow and resist drugs.